| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |